The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune- and tumor-intrinsic gene expression profiles of response or resistance to tislelizumab as monotherapy or in combination with chemotherapy in non-small cell lung cancer (NSCLC).
 
Jayesh Desai
Consulting or Advisory Role - Amgen (Inst); BeiGene; Biocon; Eisai; Lilly
Research Funding - AstraZeneca/MedImmune (Inst); BeiGene (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst)
 
Jie Wang
No Relationships to Disclose
 
Qing Zhou
Honoraria - AstraZeneca; Roche
 
Jun Zhao
No Relationships to Disclose
 
Sanjeev Deva
Travel, Accommodations, Expenses - Roche
 
Wei Tan
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Xiaopeng Ma
Employment - BeiGene; BeiGene (I)
Stock and Other Ownership Interests - BeiGene; BeiGene
 
Yun Zhang
Employment - BeiGene
 
Zhirong Shen
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Patents, Royalties, Other Intellectual Property - BeiGene
 
Xikun Wu
Employment - BeiGene; Johnson & Johnson
Stock and Other Ownership Interests - BeiGene
 
Shiangjiin Leaw
Employment - BeiGene
 
Yanjie Wu
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Yi-Long Wu
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche
Research Funding - Boehringer Ingelheim (Inst); Pfizer (Inst); Roche (Inst)